RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
All Cosmos Bio-Tech Holding Stock

All Cosmos Bio-Tech Holding EBIT 2025

All Cosmos Bio-Tech Holding EBIT

169.32 M TWD

Ticker

4148.TW

ISIN

KYG0232P1072

In 2025, All Cosmos Bio-Tech Holding's EBIT was 169.32 M TWD, a -10.83% increase from the 189.9 M TWD EBIT recorded in the previous year.

The All Cosmos Bio-Tech Holding EBIT history

YEAREBIT (undefined TWD)
2024e169.32
2023189.9
2022666.99
2021273.24
2020102.71
201973.23
2018356.77
2017406.72
2016324.6
2015283.91
2014176.78

All Cosmos Bio-Tech Holding Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into All Cosmos Bio-Tech Holding, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by All Cosmos Bio-Tech Holding from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects All Cosmos Bio-Tech Holding’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of All Cosmos Bio-Tech Holding. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into All Cosmos Bio-Tech Holding’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing All Cosmos Bio-Tech Holding’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on All Cosmos Bio-Tech Holding’s growth potential.

All Cosmos Bio-Tech Holding Revenue, EBIT and net profit per share

DateAll Cosmos Bio-Tech Holding RevenueAll Cosmos Bio-Tech Holding EBITAll Cosmos Bio-Tech Holding Net Income
2024e2.22 B undefined169.32 M undefined131.93 M undefined
20232.83 B undefined189.9 M undefined139.36 M undefined
20223.7 B undefined666.99 M undefined368.2 M undefined
20212.2 B undefined273.24 M undefined198.13 M undefined
20201.64 B undefined102.71 M undefined82.2 M undefined
20191.77 B undefined73.23 M undefined35.69 M undefined
20182.69 B undefined356.77 M undefined305.06 M undefined
20172.26 B undefined406.72 M undefined322.87 M undefined
20162.07 B undefined324.6 M undefined243.22 M undefined
20152.26 B undefined283.91 M undefined197.06 M undefined
20142.23 B undefined176.78 M undefined195.64 M undefined

All Cosmos Bio-Tech Holding stock margins

The All Cosmos Bio-Tech Holding margin analysis displays the gross margin, EBIT margin, as well as the profit margin of All Cosmos Bio-Tech Holding. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for All Cosmos Bio-Tech Holding.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the All Cosmos Bio-Tech Holding's sales revenue. A higher gross margin percentage indicates that the All Cosmos Bio-Tech Holding retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the All Cosmos Bio-Tech Holding's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the All Cosmos Bio-Tech Holding's total revenue generated. When comparing the revenue margin year over year, investors can gauge the All Cosmos Bio-Tech Holding's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the All Cosmos Bio-Tech Holding. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the All Cosmos Bio-Tech Holding's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

All Cosmos Bio-Tech Holding Margin History

All Cosmos Bio-Tech Holding Gross marginAll Cosmos Bio-Tech Holding Profit marginAll Cosmos Bio-Tech Holding EBIT marginAll Cosmos Bio-Tech Holding Profit margin
2024e20.8 %7.63 %5.94 %
202320.8 %6.72 %4.93 %
202230.73 %18.02 %9.95 %
202127.05 %12.44 %9.02 %
202022.65 %6.25 %5 %
201922.25 %4.14 %2.02 %
201828.82 %13.27 %11.35 %
201733.2 %17.97 %14.26 %
201631.73 %15.71 %11.77 %
201527.59 %12.58 %8.73 %
201425.47 %7.92 %8.77 %

All Cosmos Bio-Tech Holding Aktienanalyse

What does All Cosmos Bio-Tech Holding do?

All Cosmos Bio-Tech Holding Corp is a leading company in the field of biotechnology and agriculture. The company was founded in 1995 and is headquartered in Taiwan. It is listed on the Taiwan Stock Exchange and employs over 1,500 employees. The company is divided into five different business segments. History: All Cosmos Bio-Tech Holding Corp was founded in 1995 by Mr. Lee Guan-Hwa. Mr. Lee had a vision to promote both plants and farmers. He wanted to create a company that specialized in improving agriculture through biotechnology. The company began by manufacturing organic fertilizers and pesticides and has now grown into a leading biotechnology company with a global market. Business model: All Cosmos Bio-Tech operates an integrated biotech platform and offers a wide range of biotechnology products and services. The company has successfully built one of the world's largest manufacturing facilities for bio-fertilizers and biotech products. All Cosmos Bio-Tech focuses on continuous improvement and development of new products, as well as research into new technologies and building partnerships. Various divisions: 1. Bio-fertilizers: All Cosmos Bio-Tech uses bio-fertilizers to ensure that plants can grow and thrive naturally. The company's products are well-known worldwide and are used in agriculture in Taiwan, China, Japan, Thailand, and other countries. The company's biotech fertilizers promote soil and plant health and also increase crop yields. 2. Biotech products: All Cosmos Bio-Tech produces biotech products such as pesticides, insecticides, herbicides, and fungicides to repel pests and protect plants from diseases. These products are also well-known worldwide and provide a natural alternative to chemical pesticides and other pest control methods. 3. Animal care products: All Cosmos Bio-Tech also produces animal care products to improve the health of livestock such as poultry, pigs, and cattle. These products contain natural ingredients that strengthen the animal's immune system and keep them healthy. 4. Medicine and healthcare: All Cosmos Bio-Tech also develops biotechnology products in the field of medicine and healthcare. These products include products for the diagnosis and treatment of diseases, as well as products in the cosmetics and skincare industry. 5. Environmental protection: All Cosmos Bio-Tech is committed to preserving a green environment and promotes environmental protection. The company invests in renewable energy and contributes to an environmentally responsible business model. In conclusion, All Cosmos Bio-Tech Holding Corp is a leading company in the field of biotechnology and agriculture. Over the years, the company has become an internationally renowned biotechnology company, offering a wide range of products and services. All Cosmos Bio-Tech strives to provide a natural alternative to chemical products and promotes environmental protection and sustainability. All Cosmos Bio-Tech Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing All Cosmos Bio-Tech Holding's EBIT

All Cosmos Bio-Tech Holding's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of All Cosmos Bio-Tech Holding's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

All Cosmos Bio-Tech Holding's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in All Cosmos Bio-Tech Holding’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about All Cosmos Bio-Tech Holding stock

How much did All Cosmos Bio-Tech Holding achieve in EBIT for the current year?

In the current year, All Cosmos Bio-Tech Holding has achieved an EBIT of 169.32 M TWD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company All Cosmos Bio-Tech Holding.

How has the EBIT of All Cosmos Bio-Tech Holding developed in recent years?

The EBIT of All Cosmos Bio-Tech Holding has increased by -10.835% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company All Cosmos Bio-Tech Holding?

The EBIT of All Cosmos Bio-Tech Holding is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does All Cosmos Bio-Tech Holding pay?

Over the past 12 months, All Cosmos Bio-Tech Holding paid a dividend of 2.5 TWD . This corresponds to a dividend yield of about 5.12 %. For the coming 12 months, All Cosmos Bio-Tech Holding is expected to pay a dividend of 2.5 TWD.

What is the dividend yield of All Cosmos Bio-Tech Holding?

The current dividend yield of All Cosmos Bio-Tech Holding is 5.12 %.

When does All Cosmos Bio-Tech Holding pay dividends?

All Cosmos Bio-Tech Holding pays a quarterly dividend. This is distributed in the months of August, July, August, August.

How secure is the dividend of All Cosmos Bio-Tech Holding?

All Cosmos Bio-Tech Holding paid dividends every year for the past 7 years.

What is the dividend of All Cosmos Bio-Tech Holding?

For the upcoming 12 months, dividends amounting to 2.5 TWD are expected. This corresponds to a dividend yield of 5.12 %.

In which sector is All Cosmos Bio-Tech Holding located?

All Cosmos Bio-Tech Holding is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von All Cosmos Bio-Tech Holding kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of All Cosmos Bio-Tech Holding from 8/1/2024 amounting to 1 TWD, you needed to have the stock in your portfolio before the ex-date on 7/11/2024.

When did All Cosmos Bio-Tech Holding pay the last dividend?

The last dividend was paid out on 8/1/2024.

What was the dividend of All Cosmos Bio-Tech Holding in the year 2024?

In the year 2024, All Cosmos Bio-Tech Holding distributed 1.5 TWD as dividends.

In which currency does All Cosmos Bio-Tech Holding pay out the dividend?

The dividends of All Cosmos Bio-Tech Holding are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von All Cosmos Bio-Tech Holding

Our stock analysis for All Cosmos Bio-Tech Holding Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of All Cosmos Bio-Tech Holding Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.